Cowen And Company

Sobering Up On SAM; Cowen Says Sell Boston Beer Co.

Apple Stock Still Trading At 'Much Larger Discount' Than 3 Years Ago

The Analyst Day You Don't Want To Miss: Western Digital

Apple Stock Still Trading At 'Much Larger Discount' Than 3 Years Ago

The Analyst Day You Don't Want To Miss: Western Digital

Cautious Sentiment In Lululemon May Be Overdone Ahead Of Q3 Earnings

Pros And Cons From Core Laboratories' Q3 Earnings

Cautious Sentiment In Lululemon May Be Overdone Ahead Of Q3 Earnings

Pros And Cons From Core Laboratories' Q3 Earnings

Reynolds American's Disappointing Quarter Belies A Strong Growth Story

Sarepta Prices Newly-Approved DMD Drug, Cowen Upgrades Stock To Outperform

Cowen And Company Recent News

Nike Continues To Build A Moat Around Its Brand

Cowen Initiates Tesla At Underperform, Implies 21% Downside

Comp Sales At The Gap Slip Further Than Expected

Itron Announces Solid Q2 Results, Plans To Become Leaner

Smith & Wesson Continues Street-Beat Streak With Q1 Results

Cowen Analysts Attempt To Quantify The Effect Of Delta's Power Outage

Audentes Therapeutics' Strong Pipeline Merits An Outperform Rating From Cowen And Company

Why This Analyst Believes Oracle Is Unlikely To Acquire NetSuite

Despite Headwinds, Cowen Sees TripAdvisor Traveling Higher Long-Term

Cowen Says Ocular Therapeutix's OTX-DP Miss 'Meaningless' To Bull Thesis

Natera Shares Down 12%; Cowen Reiterated Outperform Following Meetings With Management

Cowen: JetBlue Can Overcome April Revenue 'Blues'

Netflix Will Beat U.S. Subscriber Expectations In Second Half, Cowen Predicts

Cowen Met With McDonald's Management: Here's What Happened

Is Republic Airways' Bankruptcy Weighing On Embraer?

Habit Restaurants Gets Another Vote Of Confidence

LogMeIn's LastPass Acquisition Gives Investors More Gains

Cowen Downgrades Pandora Amid 'Lower Ad Loads'

La Jolla Pharma Could Nearly Triple, Cowen Says

Cowen Upgrades ADTRAN, Sees Revenue Boost In Future From AT&T Deal

American Airlines Inflection Point Is On Its Way, Says Cowen Analyst Amid Upgrade

Pandemic Fears Could Be Major Catalyst For Cerus Drug, Cowen Says

Facebook Absolutely Crushed Earnings And The Street Is Loving It